Literature DB >> 28937364

Nucleic acid amplification testing in Indian blood banks: A review with perspectives.

Kanjaksha Ghosh1, Kanchan Mishra1.   

Abstract

BACKGROUND: Nucleic acid amplification testing (NAT) is restricted to a few blood banks in India since 2008. This review was directed toward understanding NAT yield in different parts of the country and prevalence in the NAT of different types of virus.
MATERIALS AND METHODS: English literature was searched from 1990 to 2016 in PubMed, Scopus, Ind med, and Google database using properly constructed key words. Literature was collected and finally the data were synthesized.
RESULTS: NAT results from 11 publications and one personal communication showed that till date 389387 blood units have been NAT tested from various parts of the country. NAT yield varied from 1:476 to 1:4403 in various studies. Till date, 58/2550 (2%) blood banks of India are doing NAT testing but all of them have not published their results. Majority of the centers have used ID-NAT (Individual NAT) protocol and 21 blood banks are using minipool format of the test. One center has used in-house NAT testing system. In> 70% of the time, the NAT positivity with due to hepatitis B (Hep B). For individual infection, NAT yield from the pooled data showed HIV in 1:66,000, Hep C virus 1:5484 and Hep B in 1:1761 seronegative donors. DISCUSSION AND
CONCLUSION: In view of the very high NAT yield (1:1361), NAT in some from needs to be universally applied in Indian blood banks. However, the high Hep B occult infection suggests stricter donor selection and immunization of adults for Hep B may be way forward toward ensuring the viral safety of blood components in India.

Entities:  

Mesh:

Year:  2017        PMID: 28937364     DOI: 10.4103/IJPM.IJPM_361_16

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  4 in total

1.  Significance of Adopting Nucleic Acid Amplification Technique for Blood Donor Screening in a Resource Limited Setting: A Study from a Single Centre in South India.

Authors:  Sudha Ranganathan; Ranganathan N Iyer; Nagalla Balakrishna
Journal:  Indian J Hematol Blood Transfus       Date:  2021-10-27       Impact factor: 0.915

2.  Seroprevalence of HBV, HCV and HIV-1 and Correlation with Molecular Markers among Multi-Transfused Thalassemia Patients in Western India.

Authors:  Kanchan Mishra; Avani Shah; Krima Patel; Kanjaksha Ghosh; Sumit Bharadva
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-07-01       Impact factor: 2.576

3.  Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India.

Authors:  Rekha Hans; Neelam Marwaha; Suresh Sharma; Suchet Sachdev; Ratti Ram Sharma
Journal:  Indian J Med Res       Date:  2019-05       Impact factor: 2.375

4.  Adaptation of a Public-Private Partnership Model for the Implementation of Minipool Nucleic Acid Testing for Screening Routine Blood Donations and Assay Evaluation.

Authors:  Smita Mahapatra; Pankaj Parida; Chitta Ranjan Prasad; Sabita Palai; Debashis Mishra; Susmita Behera; Rabindra Kumar Mishra; Binayak Prasad Prusty; Kalyan Sarkar
Journal:  J Lab Physicians       Date:  2022-06-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.